Investigating the association between genetically proxied circulating levels of immune checkpoint proteins and cancer survival: protocol for a Mendelian randomisation analysis
Introduction Compared with the traditional drug development pathway, investigating alternative uses for existing drugs (ie, drug repurposing) requires substantially less time, cost and resources. Immune checkpoint inhibitors are licensed for the treatment of certain breast, colorectal, head and neck...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2024-02-01
|
| Col·lecció: | BMJ Open |
| Accés en línia: | https://bmjopen.bmj.com/content/14/2/e075981.full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|